NCT05669677View on ClinicalTrials.gov

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

CompletedOBSERVATIONAL
Enrollment

233

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

April 4, 2025

Study Completion Date

April 4, 2025

Conditions
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis DNAFLDNASH
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH